Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2019 Jul 1;5(7):983-984.
doi: 10.1001/jamaoncol.2019.0812.

Racial Inequality in Prostate Cancer Outcomes-Socioeconomics, Not Biology

Affiliations
Comment

Racial Inequality in Prostate Cancer Outcomes-Socioeconomics, Not Biology

Channing J Paller et al. JAMA Oncol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Brawley reported receiving grants from the National Cancer Institute and Bloomberg Philanthropies during the conduct of the study. No other disclosures were reported.

Comment on

  • Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality.
    Dess RT, Hartman HE, Mahal BA, Soni PD, Jackson WC, Cooperberg MR, Amling CL, Aronson WJ, Kane CJ, Terris MK, Zumsteg ZS, Butler S, Osborne JR, Morgan TM, Mehra R, Salami SS, Kishan AU, Wang C, Schaeffer EM, Roach M 3rd, Pisansky TM, Shipley WU, Freedland SJ, Sandler HM, Halabi S, Feng FY, Dignam JJ, Nguyen PL, Schipper MJ, Spratt DE. Dess RT, et al. JAMA Oncol. 2019 Jul 1;5(7):975-983. doi: 10.1001/jamaoncol.2019.0826. JAMA Oncol. 2019. PMID: 31120534 Free PMC article. Clinical Trial.

References

    1. Bach PB, Schrag D, Brawley OW, Galaznik A, Yakren S, Begg CB. Survival of blacks and whites after a cancer diagnosis. JAMA. 2002;287(16): 2106–2113. doi:10.1001/jama.287.16.2106 - DOI - PubMed
    1. Freedman LS, Simon R, Foulkes MA, et al. Inclusion of women and minorities in clinical trials and the NIH Revitalization Act of 1993: the perspective of NIH clinical trialists. Control Clin Trials. 1995;16(5):277–285. doi:10.1016/0197-2456(95)00048-8 - DOI - PubMed
    1. Dess RT, Hartman HE, Mahal BA, et al. Association of black race with prostate cancer–specific and other-cause mortality. JAMA Oncol. Published online May 23, 2019. doi:10.1001/jamaoncol.2019.0826 - DOI - PMC - PubMed
    1. McNamara MA, George DJ, Ramaswamy K, et al. Overall survival by race in chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC) patients treated with abiraterone acetate or enzalutamide. J Clin Oncol. 2019;37(7_suppl):212–212. doi:10.1200/JCO.2019.37.7_suppl.212 - DOI
    1. Spratt DE, Chen Y-W, Mahal BA, et al. Individual patient data analysis of randomized clinical trials: impact of black race on castration-resistant prostate cancer outcomes. Eur Urol Focus. 2016;2 (5):532–539. doi:10.1016/j.euf.2016.03.010 - DOI - PubMed